118 related articles for article (PubMed ID: 21697722)
1. Organic cation transporter 3: expression in failing and nonfailing human heart and functional characterization.
Solbach TF; Grube M; Fromm MF; Zolk O
J Cardiovasc Pharmacol; 2011 Oct; 58(4):409-17. PubMed ID: 21697722
[TBL] [Abstract][Full Text] [Related]
2. Functional characterization of the human organic cation transporter 2 variant p.270Ala>Ser.
Zolk O; Solbach TF; König J; Fromm MF
Drug Metab Dispos; 2009 Jun; 37(6):1312-8. PubMed ID: 19251820
[TBL] [Abstract][Full Text] [Related]
3. Functional analysis of organic cation transporter 3 expressed in human placenta.
Sata R; Ohtani H; Tsujimoto M; Murakami H; Koyabu N; Nakamura T; Uchiumi T; Kuwano M; Nagata H; Tsukimori K; Nakano H; Sawada Y
J Pharmacol Exp Ther; 2005 Nov; 315(2):888-95. PubMed ID: 16081676
[TBL] [Abstract][Full Text] [Related]
4. Expression of the extraneuronal monoamine transporter in RPE and neural retina.
Rajan PD; Kekuda R; Chancy CD; Huang W; Ganapathy V; Smith SB
Curr Eye Res; 2000 Mar; 20(3):195-204. PubMed ID: 10694895
[TBL] [Abstract][Full Text] [Related]
5. Functional characterization of the organic cation transporters (OCTs) in human airway pulmonary epithelial cells.
Ingoglia F; Visigalli R; Rotoli BM; Barilli A; Riccardi B; Puccini P; Dall'Asta V
Biochim Biophys Acta; 2015 Jul; 1848(7):1563-72. PubMed ID: 25883089
[TBL] [Abstract][Full Text] [Related]
6. Targeted disruption of organic cation transporter 3 attenuates the pharmacologic response to metformin.
Chen EC; Liang X; Yee SW; Geier EG; Stocker SL; Chen L; Giacomini KM
Mol Pharmacol; 2015 Jul; 88(1):75-83. PubMed ID: 25920679
[TBL] [Abstract][Full Text] [Related]
7. Role of organic cation transporter 3 (SLC22A3) and its missense variants in the pharmacologic action of metformin.
Chen L; Pawlikowski B; Schlessinger A; More SS; Stryke D; Johns SJ; Portman MA; Chen E; Ferrin TE; Sali A; Giacomini KM
Pharmacogenet Genomics; 2010 Nov; 20(11):687-99. PubMed ID: 20859243
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of organic cation transporter 3 (SLC22A3) inhibition as a potential mechanism of antidepressant action.
Zhu HJ; Appel DI; Gründemann D; Richelson E; Markowitz JS
Pharmacol Res; 2012 Apr; 65(4):491-6. PubMed ID: 22342816
[TBL] [Abstract][Full Text] [Related]
9. Organic cation transporters OCT1, 2, and 3 mediate high-affinity transport of the mutagenic vital dye ethidium in the kidney proximal tubule.
Lee WK; Reichold M; Edemir B; Ciarimboli G; Warth R; Koepsell H; Thévenod F
Am J Physiol Renal Physiol; 2009 Jun; 296(6):F1504-13. PubMed ID: 19357179
[TBL] [Abstract][Full Text] [Related]
10. Substrate-Dependent Inhibition of the Human Organic Cation Transporter OCT2: A Comparison of Metformin with Experimental Substrates.
Hacker K; Maas R; Kornhuber J; Fromm MF; Zolk O
PLoS One; 2015; 10(9):e0136451. PubMed ID: 26327616
[TBL] [Abstract][Full Text] [Related]
11. Norepinephrine uptake mechanisms in cardiovascular disease deserve our attention.
Schroeder C; Jordan J
J Cardiovasc Pharmacol; 2011 Oct; 58(4):406-8. PubMed ID: 21975869
[No Abstract] [Full Text] [Related]
12. Determination of OATP-, NTCP- and OCT-mediated substrate uptake activities in individual and pooled batches of cryopreserved human hepatocytes.
De Bruyn T; Ye ZW; Peeters A; Sahi J; Baes M; Augustijns PF; Annaert PP
Eur J Pharm Sci; 2011 Jul; 43(4):297-307. PubMed ID: 21605667
[TBL] [Abstract][Full Text] [Related]
13. Involvement of organic cation transporter 3 (Oct3/Slc22a3) in the bioavailability and pharmacokinetics of antidiabetic metformin in mice.
Shirasaka Y; Lee N; Zha W; Wagner D; Wang J
Drug Metab Pharmacokinet; 2016 Oct; 31(5):385-388. PubMed ID: 27569291
[TBL] [Abstract][Full Text] [Related]
14. Effects of tetraalkylammonium compounds with different affinities for organic cation transporters on the pharmacokinetics of metformin.
Choi MK; Jin QR; Jin HE; Shim CK; Cho DY; Shin JG; Song IS
Biopharm Drug Dispos; 2007 Dec; 28(9):501-10. PubMed ID: 17876861
[TBL] [Abstract][Full Text] [Related]
15. Oxaliplatin transport mediated by organic cation/carnitine transporters OCTN1 and OCTN2 in overexpressing human embryonic kidney 293 cells and rat dorsal root ganglion neurons.
Jong NN; Nakanishi T; Liu JJ; Tamai I; McKeage MJ
J Pharmacol Exp Ther; 2011 Aug; 338(2):537-47. PubMed ID: 21606177
[TBL] [Abstract][Full Text] [Related]
16. Functional involvement of the organic cation transporter 2 (rOct2) in the renal uptake of organic cations in rats.
Umehara KI; Iwatsubo T; Noguchi K; Kamimura H
J Int Med Res; 2008; 36(1):123-36. PubMed ID: 18230276
[TBL] [Abstract][Full Text] [Related]
17. The organic cation transporter 3 (OCT3) as molecular target of psychotropic drugs: transport characteristics and acute regulation of cloned murine OCT3.
Massmann V; Edemir B; Schlatter E; Al-Monajjed R; Harrach S; Klassen P; Holle SK; Sindic A; Dobrivojevic M; Pavenstädt H; Ciarimboli G
Pflugers Arch; 2014 Mar; 466(3):517-27. PubMed ID: 23982114
[TBL] [Abstract][Full Text] [Related]
18. Moxifloxacin Is a Potent In Vitro Inhibitor of OCT- and MATE-Mediated Transport of Metformin and Ethambutol.
Te Brake LH; van den Heuvel JJ; Buaben AO; van Crevel R; Bilos A; Russel FG; Aarnoutse RE; Koenderink JB
Antimicrob Agents Chemother; 2016 Dec; 60(12):7105-7114. PubMed ID: 27645247
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the kinetic characteristics of inhibitory effects exerted by biguanides and H2-blockers on human and rat organic cation transporter-mediated transport: Insight into the development of drug candidates.
Umehara KI; Iwatsubo T; Noguchi K; Kamimura H
Xenobiotica; 2007 Jun; 37(6):618-34. PubMed ID: 17614008
[TBL] [Abstract][Full Text] [Related]
20. Human organic cation transporter 3 mediates the transport of antiarrhythmic drugs.
Hasannejad H; Takeda M; Narikawa S; Huang XL; Enomoto A; Taki K; Niwa T; Jung SH; Onozato ML; Tojo A; Endou H
Eur J Pharmacol; 2004 Sep; 499(1-2):45-51. PubMed ID: 15363950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
